1 active not recruiting, 1 completed, 1 not yet recruiting, 1 recruiting. 3 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Active not recruiting 1, Not yet recruiting 1, Recruiting 1 |
| Phase 3 | 1 | Completed 1 |
Follow Thalidomide (100mg): new trials by email Literature Review of Thalidomide (100mg) trials Research Report on Thalidomide (100mg)
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| The Efficacy of CAPCT in Patients With PTCL Chidamide, Azacitidine (AZA), Prednisone - Peripheral T-Cell Lymphoma | Phase 2 | Not yet recruiting | The First Affiliated Hospital with Nanjing Medical University | 58 | 2026-08-01 | 2026-08-05 |
| Efficacy and Safety of XTD Regimen (Selinexor, Thalidomide and Dexamethasone) in Adult Patients With Relapsed/Refractory LCH Selinexor, Thalidomide (100mg), Dexamethasone - Langerhans Cell Histiocytosis (LCH) | Phase 2 | Active not recruiting | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | 40 | 2025-08-01 | 2025-10-02 |
| Efficacy and Safety of Low-Dose Cytarabine Combined With Thalidomide in Adult Patients With Untreated LCH Cytarabine (Ara-C), Thalidomide (100mg) - Langerhans Cell Histiocytosis | Phase 2 | Recruiting | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | 50 | 2025-04-12 | 2025-09-22 |
| the Efficiency of Thalidomide for Recurrent Small Intestinal Bleeding Due to Gastrointestinal Vascular Malformation Thalidomide (100mg), Thalidomide (50mg), placebo - Gastrointestinal Vascular Malformation | Phase 3 | Completed | Shanghai Jiao Tong University School of Medicine | 150 | 2016-04-01 | 2023-06-23 |
Histiocytosis, Langerhans-Cell (2) · Lymphoma, T-Cell, Peripheral (1)
Cancer Institute and Hospital, Chinese Academy of Medical Sciences (2) · Shanghai Jiao Tong University School of Medicine (1) · The First Affiliated Hospital with Nanjing Medical University (1)
China (4)
PMID 17254484, PMID 18031363, PMID 21784047, PMID 21955427, PMID 22098296, PMID 24219762, PMID 37913505